Literature DB >> 25389293

Relaxin activates peroxisome proliferator-activated receptor γ (PPARγ) through a pathway involving PPARγ coactivator 1α (PGC1α).

Sudhir Singh1, Ronda L Simpson1, Robert G Bennett2.   

Abstract

Relaxin activation of its receptor RXFP1 triggers multiple signaling pathways. Previously, we have shown that relaxin activates PPARγ transcriptional activity in a ligand-independent manner, but the mechanism for this effect was unknown. In this study, we examined the signaling pathways of downstream of RXFP1 leading to PPARγ activation. Using cells stably expressing RXFP1, we found that relaxin regulation of PPARγ activity requires accumulation of cAMP and subsequent activation of cAMP-dependent protein kinase (PKA). The activated PKA subsequently phosphorylated cAMP response element-binding protein (CREB) at Ser-133 to activate it directly, as well as indirectly through mitogen activated protein kinase p38 MAPK. Activated CREB was required for relaxin stimulation of PPARγ activity, while there was no evidence for a role of the nitric oxide or ERK MAPK pathways. Relaxin increased the mRNA and protein levels of the coactivator protein PGC1α, and this effect was dependent on PKA, and was completely abrogated by a dominant-negative form of CREB. This mechanism was confirmed in a hepatic stellate cell line stably that endogenously expresses RXFP1. Reduction of PGC1α levels using siRNA diminished the regulation of PPARγ by relaxin. These results suggest that relaxin activates the cAMP/PKA and p38 MAPK pathways to phosphorylate CREB, resulting in increased PGC1α levels. This provides a mechanism for the ligand-independent activation of PPARγ in response to relaxin.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Peroxisome Proliferator-activated Receptor γ Coactivator 1-α (PGC-1a)(PPARGC1A); Peroxisome Proliferator-activated receptor (PPAR); Protein Kinase A (PKA); Relaxin; Relaxin Family Peptide Receptor 1 (RXFP1); cAMP Response Element-binding Protein (CREB); p38 MAPK

Mesh:

Substances:

Year:  2014        PMID: 25389293      PMCID: PMC4294522          DOI: 10.1074/jbc.M114.589325

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Inhibition of markers of hepatic stellate cell activation by the hormone relaxin.

Authors:  Robert G Bennett; Kusum K Kharbanda; Dean J Tuma
Journal:  Biochem Pharmacol       Date:  2003-09-01       Impact factor: 5.858

2.  Activation of orphan receptors by the hormone relaxin.

Authors:  Sheau Yu Hsu; Koji Nakabayashi; Shinya Nishi; Jin Kumagai; Masataka Kudo; O David Sherwood; Aaron J W Hsueh
Journal:  Science       Date:  2002-01-25       Impact factor: 47.728

3.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1.

Authors:  S Herzig; F Long; U S Jhala; S Hedrick; R Quinn; A Bauer; D Rudolph; G Schutz; C Yoon; P Puigserver; B Spiegelman; M Montminy
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

4.  Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.

Authors:  G Lazennec; L Canaple; D Saugy; W Wahli
Journal:  Mol Endocrinol       Date:  2000-12

5.  Relaxin activates the MAP kinase pathway in human endometrial stromal cells.

Authors:  Qiang Zhang; Shu-Hui Liu; Mark Erikson; Martyn Lewis; Elaine Unemori
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

6.  Phosphoinositide 3-kinase activity is required for biphasic stimulation of cyclic adenosine 3',5'-monophosphate by relaxin.

Authors:  Bao T Nguyen; Luping Yang; Barbara M Sanborn; Carmen W Dessauer
Journal:  Mol Endocrinol       Date:  2003-02-20

7.  Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.

Authors:  Marc Iglarz; Rhian M Touyz; Emilie C Viel; Pierre Paradis; Farhad Amiri; Quy N Diep; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2003-07-14       Impact factor: 10.190

8.  An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle.

Authors:  Christoph Handschin; James Rhee; Jiandie Lin; Paul T Tarr; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-22       Impact factor: 11.205

9.  Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-kappaB.

Authors:  Thomas Dschietzig; Cornelia Bartsch; Christoph Richter; Michael Laule; Gert Baumann; Karl Stangl
Journal:  Circ Res       Date:  2003-01-10       Impact factor: 17.367

10.  Ligand and coactivator identity determines the requirement of the charge clamp for coactivation of the peroxisome proliferator-activated receptor gamma.

Authors:  Yifei Wu; William W Chin; Yong Wang; Thomas P Burris
Journal:  J Biol Chem       Date:  2002-12-26       Impact factor: 5.157

View more
  22 in total

1.  Cardiac myocyte p38α kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart.

Authors:  Beth A Rose; Tomohiro Yokota; Vishnu Chintalgattu; Shuxun Ren; Luisa Iruela-Arispe; Aarif Y Khakoo; Susumu Minamisawa; Yibin Wang
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

2.  PPARγ Regulates Mitochondrial Structure and Function and Human Pulmonary Artery Smooth Muscle Cell Proliferation.

Authors:  Samantha M Yeligar; Bum-Yong Kang; Kaiser M Bijli; Jennifer M Kleinhenz; Tamara C Murphy; Gloria Torres; Alejandra San Martin; Roy L Sutliff; C Michael Hart
Journal:  Am J Respir Cell Mol Biol       Date:  2018-05       Impact factor: 6.914

3.  Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insights.

Authors:  Chen Huei Leo; Hooi Hooi Ng; Sarah A Marshall; Maria Jelinic; Thusitha Rupasinghe; Chengxue Qin; Ute Roessner; Rebecca H Ritchie; Marianne Tare; Laura J Parry
Journal:  Br J Pharmacol       Date:  2019-10-31       Impact factor: 8.739

Review 4.  Heart Disease and Relaxin: New Actions for an Old Hormone.

Authors:  Teja Devarakonda; Fadi N Salloum
Journal:  Trends Endocrinol Metab       Date:  2018-03-08       Impact factor: 12.015

5.  Protein Kinase A/CREB Signaling Prevents Adriamycin-Induced Podocyte Apoptosis via Upregulation of Mitochondrial Respiratory Chain Complexes.

Authors:  Kewei Xie; Mingli Zhu; Peng Xiang; Xiaohuan Chen; Ayijiaken Kasimumali; Renhua Lu; Qin Wang; Shan Mou; Zhaohui Ni; Leyi Gu; Huihua Pang
Journal:  Mol Cell Biol       Date:  2017-12-13       Impact factor: 4.272

6.  Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis.

Authors:  Elena M Kaftanovskaya; Hooi Hooi Ng; Mariluz Soula; Bryan Rivas; Courtney Myhr; Brian A Ho; Briana A Cervantes; Thomas D Shupe; Mahesh Devarasetty; Xin Hu; Xin Xu; Samarjit Patnaik; Kenneth J Wilson; Elena Barnaeva; Marc Ferrer; Noel T Southall; Juan J Marugan; Colin E Bishop; Irina U Agoulnik; Alexander I Agoulnik
Journal:  FASEB J       Date:  2019-08-16       Impact factor: 5.191

Review 7.  Anti-fibrotic actions of relaxin.

Authors:  C S Samuel; S G Royce; T D Hewitson; K M Denton; T E Cooney; R G Bennett
Journal:  Br J Pharmacol       Date:  2016-07-07       Impact factor: 8.739

8.  Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes.

Authors:  A Aragón-Herrera; S Feijóo-Bandín; D Rodríguez-Penas; E Roselló-Lletí; M Portolés; M Rivera; M Bigazzi; D Bani; O Gualillo; J R González-Juanatey; F Lago
Journal:  Endocrine       Date:  2018-02-06       Impact factor: 3.633

9.  Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.

Authors:  Wen Li; Zhihui Zhang; Kai Zhang; Zhenyi Xue; Yan Li; Zimu Zhang; Lijuan Zhang; Chao Gu; Qi Zhang; Junwei Hao; Yurong Da; Zhi Yao; Ying Kong; Rongxin Zhang
Journal:  Mol Neurobiol       Date:  2015-10-06       Impact factor: 5.590

Review 10.  G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention.

Authors:  Kirk P Conrad
Journal:  Hum Reprod Update       Date:  2016-07-06       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.